SPONSOR
Harbin Medical University
Total Trials
3
Recruiting
3
Phases
N/A
Conditions studied: Acute Coronary Syndrome (ACS)Autism Spectrum DisorderGastric Cancer or Gastroesophageal Junction Adenocarcinoma
Harbin Medical University is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Acute Coronary Syndrome (ACS), Autism Spectrum Disorder, Gastric Cancer or Gastroesophageal Junction Adenocarcinoma.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Harbin Medical University
How many clinical trials has Harbin Medical University sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Harbin Medical University, of which 3 are actively recruiting participants. These trials cover conditions including Acute Coronary Syndrome (ACS), Autism Spectrum Disorder, Gastric Cancer or Gastroesophageal Junction Adenocarcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Harbin Medical University research focus on?
Harbin Medical University clinical trials span Acute Coronary Syndrome (ACS), Autism Spectrum Disorder, Gastric Cancer or Gastroesophageal Junction Adenocarcinoma. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Harbin Medical University clinical trial?
To participate in a Harbin Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Harbin Medical University trials with current recruitment status updated daily.
Clinical Trials by Harbin Medical University
NCT06449274
Recruiting
RESTORE Imaging: an OCT-IVUS Imaging Substudy of RESTORE Trial
Acute Coronary Syndrome (ACS)
NCT06348992
Recruiting
ACT Combined Yoga for Parental Burnout in Parents with Autistic Children
Autism Spectrum Disorder
NCT07552402
Recruiting
Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer
Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology